Research and Development



Please view our Safe Harbor Statement

Capstone Therapeutics is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with under-served conditions. The Company is focused on the development and commercialization of Apo E mimetic peptide AEM-28 and analogs (through its investment in LipimetiX Development LLC).

AEM-28

  See www.LipimetiX.com